LifeVantage Corporation

LifeVantage Corporation

LFVNยทNASDAQ

$8.32

-0.18%
Consumer DefensivePackaged Foods

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.

At a Glance

Live Snapshot
Market Cap$104.96M
EPS0.8000
P/E Ratio10.40
Earnings Date08/25/2026
3Y+49.0%
5Y-35.0%
10Y+98.0%
3Y-11.0%
5Y-49.0%
10Y+143.0%
3Y-15.0%
5Y-39.0%
10Y-35.0%
LFVN

LifeVantage Corporation Cash Conversion Engine

LFVN ยท NASDAQ
Net Income9.80M
Depreciation & Amortization3.16M
Stock-Based Compensation5.70M
Change in Working Capital-6.55M
Others1.47M
Capital Expenditures-1.37M
Free Cash Flow10.51M

Cash Flow Quality Analysis

FCF Conversion Rate

107.2%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

11.5%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+5.6%

Steady FCF growth indicates consistent cash generation improvement. On a positive trajectory.

Working Capital Impact

-$6.55M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.

LifeVantage Corporation Cash Flow Statement

LFVN โ€ข NASDAQ

LifeVantage Corporation Cash Flow StatementJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
OPERATING ACTIVITIES
9.8M
2.9M
2.5M
3.1M
3.1M
11.5M
7.4M
5.8M
1.6M
6M
7M
11.4M
7.6M
12.5M
-50.8M
-11M
-9.1M
-2.1M
-3.7M
-2.7M
3.2M
3.6M
3.6M
3.3M
3.3M
5.1M
1.9M
1.3M
1.6M
1.9M
2.3M
2.1M
1.7M
521.3K
214.7K
254.9K
179.7K
219.7K
92.4K
265.3K
-1.7M
-1.3M
-1.7M
-81K
-81K
364K
563K
831K
-740K
-2.6M
91K
2.2M
-892K
-2.7M
50.8M
0.0
0.0
-322.2B
0.0
0.0
5.7M
3.3M
3.2M
1.8M
1.8M
4.9M
5.5M
3.2M
2.6M
2.6M
1.8M
3M
2.2M
1.3M
766.5K
2.7M
1.5M
322.2B
0.0
0.0
1.5M
1.3M
1.8M
4M
4M
46K
42K
32K
381K
3.1M
453K
281K
3.9M
6.8M
3.3M
3.5M
1.2M
687.3K
1.3M
96.7K
(4.9M)
(2.3M)
(1.9M)
(0.0)
(0.0)
(1.6M)
(1.3M)
(2.9M)
(5.5M)
(1.4M)
-1.7M
-4.9M
-6.1M
-3.7M
-56K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-6.6M
2.4M
-2.6M
-4.1M
-4.1M
-3.7M
2.3M
2.1M
1.1M
-5.1M
1.6M
-6.8M
-3.8M
1M
445.5K
168.6K
1.1M
399.6K
-799.7K
1.5M
11.9M
12.2M
6.8M
8M
8M
18.3M
17.8M
13.3M
6.6M
6M
13.2M
12.1M
10.7M
19.4M
4.7M
-4.5M
-5.2M
-747.8K
-3.1M
-915.6K
INVESTING ACTIVITIES
-1.4M
-2.2M
-3.1M
-1.5M
-1.5M
-2.7M
-2.5M
-4.6M
-1.1M
-562K
-1.2M
-2.2M
-5.1M
-2.2M
-164K
-46.7K
-245.5K
-70.3K
-60.2K
-136.4K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-354.7B
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-1.5M
(0.0)
-3.1M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
350K
75K
225K
450K
425K
3.1M
0.0
4K
0.0
8K
0.0
0.0
-2.7M
-2M
-4.6M
-1.1M
-562K
-1.2M
-350K
-5.1M
-1.9M
-89K
178.3K
0.0
354.7B
58.6K
-59.9K
-1.4M
-2.2M
-3.1M
-1.5M
-1.5M
-2.7M
-4.5M
-4.6M
-1.1M
-562K
-1.2M
-2.2M
-5.1M
-1.9M
-89K
(178.3K)
(204.5K)
-1.2M
(3.1M)
-3.3M
FINANCING ACTIVITIES
-5.5M
-7.4M
-771K
-8.6M
-9.1M
-11.7M
-7.8M
-1.5M
0.0
0.0
-9.9M
-46.2M
-7.1M
-976K
169.2K
916.3K
5.5M
453.6K
150.0
0.0
0.0
0.0
0.0
0.0
0.0
-1.5M
-4M
-2M
-2M
-12.1M
-9.2M
29.7M
0.0
-434K
0.0
-189.9K
405K
164.3K
-2K
-1.2K
-2.1M
-6.9M
-1.6M
-378K
-378K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-5.8M
-7.7M
-1M
-9.1M
-9.1M
-11.7M
-7.8M
-1.5M
(0.0)
(0.0)
-9.9M
-46.2M
-7.1M
-976.1K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
0.0
-97K
0.0
0.0
505K
729K
701K
1K
42K
428K
596K
717K
3.1M
2.2M
0.0
4.7M
-522.5K
1.3M
0.0
0.0
-7.6M
-14.4M
-2.4M
-9M
-9M
-12.4M
-11.1M
-3.5M
-2M
-11.7M
-18.5M
-15.8M
-4M
745.4K
169.2K
5.4M
5.4M
2M
-1.8K
-1.2K
CASH FLOW SUMMARY
402K
-254K
3K
-461K
-461K
91K
10K
86K
-9K
251K
-90K
35K
92K
38.5K
-27.9K
-31.8K
0.0
0.0
0.0
0.0
3.3M
-4.7M
1.4M
-3M
-3M
3.3M
2.2M
5.2M
3.6M
-6M
-6.5M
-5.9M
1.7M
18.3M
4.7M
1M
411.9K
36.1K
-67.4K
-4.2M
16.9M
21.6M
20.2M
23.2M
23.2M
18.8M
16.7M
11.5M
7.9M
13.9M
20.4M
26.3M
24.6M
6.4M
1.6M
608.8K
196.9K
160.8K
228.1K
4.4M
20.2M
16.9M
21.6M
20.2M
20.2M
22.1M
18.8M
16.7M
11.5M
7.9M
13.9M
20.4M
26.3M
24.6M
6.4M
1.6M
608.8K
196.9K
160.8K
228.1K
10.5M
10M
3.8M
6.4M
6.4M
15.6M
15.3M
8.6M
5.5M
5.4M
12.1M
9.9M
5.6M
17.1M
4.5M
-4.5M
-5.5M
-818.1K
-3.2M
-1.1M

SEC Filings

LFVN - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 06, 2026
May 06, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 06, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 16, 2026
April 13, 2026
2026
S-3

S-3

N/A

March 10, 2026
March 10, 2026
ย 
8-K

8-K 2026

N/A

February 04, 2026
January 30, 2026
2026
10-Q

10-Q 2025 Q4

Q4

February 04, 2026
December 31, 2025
2025
8-K

8-K 2025

N/A

December 09, 2025
December 03, 2025
2025
8-K

8-K 2025

N/A

November 12, 2025
November 06, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 04, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 04, 2025
November 04, 2025
2025
Showing 1 to 10 of 396 filings